18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions

Background Few studies have evaluated the accumulation of 18F-fluorodeoxyglucose (FDG), 11C-methionine (MET), and other positron emission tomography (PET) tracers in patients with demyelinating disease. Purpose This study aimed to investigate the accumulation of FDG-PET/computed tomograph...

Full description

Saved in:
Bibliographic Details
Main Authors: Noriaki Tomura, Toshiyuki Saginoya, Chikako Kaneko
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-12-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1750012
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849737638999752704
author Noriaki Tomura
Toshiyuki Saginoya
Chikako Kaneko
author_facet Noriaki Tomura
Toshiyuki Saginoya
Chikako Kaneko
author_sort Noriaki Tomura
collection DOAJ
description Background Few studies have evaluated the accumulation of 18F-fluorodeoxyglucose (FDG), 11C-methionine (MET), and other positron emission tomography (PET) tracers in patients with demyelinating disease. Purpose This study aimed to investigate the accumulation of FDG-PET/computed tomography (CT) and MET-PET/CT in demyelinating lesions. Material and Methods A retrospective search of the patient database in our hospital identified five patients with demyelinating disease in whom PET studies performed in the past 10 years revealed accumulation of FDG or MET. The clinical diagnoses were multiple sclerosis (n=1), myelitis (n=1), limbic encephalitis (n=1), chronic inflammatory demyelinating polyneuropathy (CIDP; n=1), and acute demyelinating encephalomyelitis (ADEM; n=1). Two patients received FDG-PET/CT alone and three patients received both FDG-PET/CT and MET-PET/CT on the same day. Images were visually and conjointly reviewed by two radiologists. In semiquantitative evaluation, the maximum standardized uptake value (SUVmax) of the lesion was measured. The lesion-to-normal brain uptake ratio (L/N ratio) was calculated. Results FDG and/or MET accumulated to a part of the lesions seen on MRI. SUVmax on FDG-PET/CT ranged from 3.8 to 10.3, and L/N ratio on MET-PET/CT ranged from 16.6 to 2.4. Conclusion It has been established that neoplastic and demyelinating lesions can be differentiated on the basis of FDG or MET uptake. However, as accumulation of FDG and MET can also occur in demyelinating lesions; knowledge of this possibility is of clinical importance.
format Article
id doaj-art-8db89eecb92944628a4f6548c2cd662f
institution DOAJ
issn 1450-1147
1607-3312
language English
publishDate 2022-12-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-8db89eecb92944628a4f6548c2cd662f2025-08-20T03:06:51ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122022-12-01210426126610.1055/s-0042-175001218F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating LesionsNoriaki Tomura0Toshiyuki Saginoya1Chikako Kaneko2Department of Neuroradiology, Radiology, and Neurology, Southern Tohoku Research Institute for Neuroscience, Southern Tohoku General Hospital, Koriyama City, Fukushima, JapanDepartment of Neuroradiology, Radiology, and Neurology, Southern Tohoku Research Institute for Neuroscience, Southern Tohoku General Hospital, Koriyama City, Fukushima, JapanDepartment of Neuroradiology, Radiology, and Neurology, Southern Tohoku Research Institute for Neuroscience, Southern Tohoku General Hospital, Koriyama City, Fukushima, JapanBackground Few studies have evaluated the accumulation of 18F-fluorodeoxyglucose (FDG), 11C-methionine (MET), and other positron emission tomography (PET) tracers in patients with demyelinating disease. Purpose This study aimed to investigate the accumulation of FDG-PET/computed tomography (CT) and MET-PET/CT in demyelinating lesions. Material and Methods A retrospective search of the patient database in our hospital identified five patients with demyelinating disease in whom PET studies performed in the past 10 years revealed accumulation of FDG or MET. The clinical diagnoses were multiple sclerosis (n=1), myelitis (n=1), limbic encephalitis (n=1), chronic inflammatory demyelinating polyneuropathy (CIDP; n=1), and acute demyelinating encephalomyelitis (ADEM; n=1). Two patients received FDG-PET/CT alone and three patients received both FDG-PET/CT and MET-PET/CT on the same day. Images were visually and conjointly reviewed by two radiologists. In semiquantitative evaluation, the maximum standardized uptake value (SUVmax) of the lesion was measured. The lesion-to-normal brain uptake ratio (L/N ratio) was calculated. Results FDG and/or MET accumulated to a part of the lesions seen on MRI. SUVmax on FDG-PET/CT ranged from 3.8 to 10.3, and L/N ratio on MET-PET/CT ranged from 16.6 to 2.4. Conclusion It has been established that neoplastic and demyelinating lesions can be differentiated on the basis of FDG or MET uptake. However, as accumulation of FDG and MET can also occur in demyelinating lesions; knowledge of this possibility is of clinical importance.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1750012 18f fluorodeoxy glucose 11c methioninedemyelinating disease
spellingShingle Noriaki Tomura
Toshiyuki Saginoya
Chikako Kaneko
18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
World Journal of Nuclear Medicine
18f fluorodeoxy glucose
11c methionine
demyelinating disease
title 18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
title_full 18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
title_fullStr 18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
title_full_unstemmed 18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
title_short 18F-Fluorodeoxy Glucose and 11C-Methionine Accumulation in Demyelinating Lesions
title_sort 18f fluorodeoxy glucose and 11c methionine accumulation in demyelinating lesions
topic 18f fluorodeoxy glucose
11c methionine
demyelinating disease
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1750012
work_keys_str_mv AT noriakitomura 18ffluorodeoxyglucoseand11cmethionineaccumulationindemyelinatinglesions
AT toshiyukisaginoya 18ffluorodeoxyglucoseand11cmethionineaccumulationindemyelinatinglesions
AT chikakokaneko 18ffluorodeoxyglucoseand11cmethionineaccumulationindemyelinatinglesions